{"id":"W2956922351","doi":"10.1158/1078-0432.ccr-19-0298","title":"Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Juravinski Cancer Centre; Spinal Cord Injury BC; Canadian Cancer Society; Espace pour la vie","funders":"Innate Pharma","keywords":"Medicine; Nausea; Vomiting; Pharmacodynamics; Internal medicine; Adverse effect; Cohort; Tolerability; Gastroenterology; Cancer; Cervical cancer; Endometrial cancer; Response Evaluation Criteria in Solid Tumors; Pharmacokinetics; Clinical trial; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002095011,0.0009684339,0.0009025602,0.000247654,0.0004439872,0.0005553021,0.0006580684,0.0007588696,0.00219606],"category_scores_gemma":[0.001215236,0.000409177,0.0007192903,0.0002352165,0.0005779485,0.0004657782,0.0003019805,0.002277804,0.0003822077],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001237507,"about_ca_system_score_gemma":0.001571806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002700725,"about_ca_topic_score_gemma":0.006074576,"domain_scores_codex":[0.9994612,0.000274587,0.00002091682,0.00007935698,0.00006470815,0.00009915375],"domain_scores_gemma":[0.9992486,0.0001204601,0.000161137,0.0001097039,0.00006110636,0.0002989692],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8276051,0.05497491,0.01089666,0.0003149424,0.001200381,0.0001308902,0.00044834,0.001701616,0.02509683,0.0002025928,0.003700775,0.07372698],"study_design_scores_gemma":[0.5965937,0.3692268,0.02582233,0.00002363459,0.0005586335,0.0001759533,0.00005462905,0.001194029,0.003054243,0.0001254397,0.003138489,0.00003211002],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996548,0.000714484,0.0001668222,0.0002419934,0.000049042,0.001142074,0.0002974333,0.00002964737,0.0008106131],"genre_scores_gemma":[0.9962289,0.0003759523,0.0005724134,0.0004045605,0.00008234425,0.0008690359,0.0004850753,0.000008303009,0.0009734839],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002700725,"threshold_uncertainty_score":0.01107961,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.142373434106831,"score_gpt":0.4662813181220757,"score_spread":0.3239078840152447,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}